Cove Therapeutics, Inc.
PrivateLast Round
Series A
Oct 7, 2022
Company Overview
Cove Therapeutics, Inc. is a biotechnology company that develops biodegradable polymeric nanoparticles for non-lipid, non-viral genetic medicine delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cove Therapeutics, Inc. Comparables
Compare Cove Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanite, Inc. | 86% | |
| BreezeBio | 86% | |
| Alaya.bio | 83% |
Cove Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2022
Completed a Series A funding round.
Cove Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cove Therapeutics, Inc.'s valuation, stock price, and market status.
Is Cove Therapeutics, Inc. a public or private company?
Cove Therapeutics, Inc. is a private company.
What is the current stock price of Cove Therapeutics, Inc.?
Cove Therapeutics, Inc. is a private company with no public stock price. Caplight tracks Cove Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Cove Therapeutics, Inc. worth (valuation)?
Valuation information for Cove Therapeutics, Inc. is not publicly available.
Can I buy Cove Therapeutics, Inc. stock?
Cove Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cove Therapeutics, Inc.'s last funding round?
Cove Therapeutics, Inc.'s most recent funding round was Series A on October 7, 2022.
Who are the main investors in Cove Therapeutics, Inc.?
Investor information for Cove Therapeutics, Inc. is not publicly disclosed.
Will Cove Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Cove Therapeutics, Inc..
How can I track Cove Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cove Therapeutics, Inc.'s secondary market activity and sign up for updates.